Showing results (41-50 of 816) with videos related to
Sort By:
Pageof 82
Current Opinion in Nephrology and Hypertension|December 26, 2001
Routine renin-angiotensin system blockade in renal transplantation?Giuseppe Remuzzi, Norberto PericoKidney International|October 16, 2008
Candesartan and renal protection: more than blocking angiotensin type 1 receptor?Daniela Macconi, Giuseppe RemuzziTrends in Endocrinology and Metabolism: TEM|October 11, 2012
Renal progenitors in non-diabetic and diabetic nephropathiesPaola Romagnani, Giuseppe RemuzziNephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 21, 2023
C3G and Ig-MPGN-treatment standardMarina Noris, Giuseppe RemuzziTissue Engineering. Part A|December 11, 2013
Recellularization of well-preserved acellular kidney scaffold using embryonic stem cellsBarbara Bonandrini, Marina Figliuzzi, Evangelia Papadimou, et al.Nephron|December 23, 2014
Effects of MCP-1 inhibition by bindarit therapy in a rat model of polycystic kidney diseaseCarlamaria Zoja, Daniela Corna, Monica Locatelli, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 5, 2010
Burden of CKD, proteinuria, and cardiovascular risk among Chinese, Mongolian, and Nepalese participants in the International Society of Nephrology screening programsSanjib Kumar Sharma, Hequn Zou, Ariunaa Togtokh, et al.American Journal of Physiology. Renal Physiology|August 14, 2009
Unlike each drug alone, lisinopril if combined with avosentan promotes regression of renal lesions in experimental diabetesElena Gagliardini, Daniela Corna, Carla Zoja, et al.Annali Dell'Istituto Superiore Di Sanita|March 25, 2011
Why rare diseases?Giuseppe Remuzzi, Arrigo SchieppatiCurrent Opinion in Nephrology and Hypertension|October 10, 2018
Mesenchymal stromal cells in kidney transplantationFederica Casiraghi, Giuseppe RemuzziPageof 82